CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy
Miriam Kim(Washington University in St. Louis), John F. DiPersio(Washington University in St. Louis)
Cited by 40
Related Papers
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity
|Nature Communications|2022|95